服务热线
400-0689-033
| 品牌 | 货号 | 产品名称 | 描述 | CAS | 规格 | 单价（￥） | 货期 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
| NIBSC | 11/106 | Influenza Virus infectious A/Perth/16/2009 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/108 | Influenza Virus infectious NYMC X-187 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/126 | Factors II and X Concentrate (4th International standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/130 | Influenza Virus Infectious NIBRG-14 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/134 | Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/170 | Erythropoietin, recombinant, for Bioassay (3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/176 | (3rd International Standard) Low Molecular Weight Heparin | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/184 | High Molecular Weight Urokinase(2nd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/206 | Influenza anti-A/Perth/16/2009 HA Serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/210 | Anti-human CD4 FITC conjugated 0.5ml | European Certification | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/214 | Blood Group Genotyping Reference Panel ((International Reference Reagent) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/216 | Chagas Antibody Reference Panel ( 1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/218 | MLH1/MSH2 Exon Copy Number Reference Panel | European Certification | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/222 | Influenza Virus Infectious NIB-79 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/226 | Influenza Virus Infectious A/Victoria/361/2011 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/232 | Influenza Virus Infectious B/Texas/6/2011 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/234 | Immunoglobulin E(IgE) human serum (3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/242 | Viral Multiplex Reference | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/244 | Influenza Virus Infectiious NYMC BX-49 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/B604 | QCRFLUAH5QC1 Influenza H5 PC1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/B606 | QCRNEGQC1-Negative Quality Control Serum: Sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/B608 | QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/100 | Influenza Virus Infectious NYMC X-217 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/104 | International Standard for IPV 12/104 (3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/106 | Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/110 | Influenza Antigen B/Wisconsin/1/2010 (cell derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/112 | Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/114 | Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/116 | Influenza anti-A/Victoria/361/2011-like HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/118 | Influenza anti-B/Wisconsin/1/2010-like HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/122 | Influenza virus infectious A/turkey/Italy/3889/1999 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/154 | Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/176 | Methylated Human Serum Albumin (mHSA) | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/188 | Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/198 | Influenza virus infectious B/Wisconsin/1/2010 34490 E5 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/202 | Influenza virus infectious NYMC BX-39 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/204 | Influenza Virus infectious IVR-165 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/208 | Parvovirus B19 (3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/224 | HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation) | International Reference Preparation | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/226 | HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/244 | Vi polysaccharide of C freundii WHO 1st International Standard | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/252 | ADAMTS 13 Plasma (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/282 | Diphtheria Toxin 1Lf/ml | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/284 | Anti-meningococcal serogroup Y monoclonal antibody | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/290 | Influenza Virus Infectious B/Brisbane/36/2012 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/294 | Influenza Virus Infectious NYMC BX-51C | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/298 | Influenza Virus Infectious A/Texas/50/2012 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/306 | Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/B611 | Anti-VZV Quality control serum: Sample 1 QCRVZVIgMQC1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/B612 | QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/B613 | QCRRUBQC2-Anti-Rubella: Quality Control Serum: Sample 2 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/100 | Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/106 | Influenza Antigen B/Massachusetts/02/2012 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/108 | Anti-Meningococcal serogroup B monoclonal antibody | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/112 | Influenza Antigen A/Texas/50/2012 (NYMC X-223) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/116 | Influenza Antigen A/Texas/50/2012 (NYMC X-223A) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/122 | Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/126 | Influenza anti-B/Brisbane/60/2008-like HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/128 | Influenza Virus Infectious NIBRG-269 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/132 | Antibodies, Human, to Toxoplasma gondii (4th International Standard). | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/134 | Influenza Antigen B/Massachusetts/02/2012 (Egg derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/146 | C-Peptide, Human (1st International Standard). | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/152 | Influenza Antigen B/Massachusetts/02/2012 (cell derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/162 | Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/164 | Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/166 | Influenza anti-A/Anhui/1/2013 (N9) NA Serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/168 | Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques | Clinical Virology Network | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/172 | Lupus Anticoagulant (1st International Reference Panel) | International Reference Preparation | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/176 | Influenza Virus Infectious NIBRG-88 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/178 | Influenza Anti-A/Texas/50/2012-like HA Serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/182 | Influenza Anti-B/Massachusetts/02/2012-like HA Serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/198 | Influenza Virus Infectious NYMC X-181 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/200 | Influenza Virus Infectious NIB-74 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/202 | Influenza Virus Infectious NIB-74xp | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/204 | TNF Rec II- FC Fusion protein (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/206 | Plasmin (4th International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/212 | Diphtheria Toxoid for use in Flocculation Test (3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/214 | HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel) | International Reference Preparation | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/216 | Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/218 | Polio Anti Sabin type 1 (inactivated) Serum | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/220 | Polio Anti Sabin type 2 (inactivated) serum | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/222 | Polio Anti Sabin type 3 (inactivated) serum | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/224 | Influenza virus Infectious NIB-85. 36210 E5 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/228 | Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/234 | Influenza antigen B/Brisbane/60/08 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/238 | Anti-EV71 serum LOW (WHO International Reference Reagent) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/242 | FEIBA Concentrate 2nd NIBSC Working Reference Standard | Working Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/246 | Meningococcal serogroup A polysaccharide (1st WHO International Standard). | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/248 | Influenza virus infectious NIBRG-267 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/250 | Influenza Virus Infectious NIBRG-268 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/252 | Influenza virus infectious NYMC X-223A | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/256 | Influenza virus infectious. NYMC x-233 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/258 | Influenza virus infectious NYMC X-233A | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/262 | Meningococcal serogroup A polysaccharide | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/264 | Influenza Virus Infectious NYMC X-223 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B627 | QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B629 | QCRHBeQC1-Anti-HBe Quality Control Serum: sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B634 | QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B636 | QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B640 | QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B642 | QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B644 | QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B650 | QCRCMVQC1- Anti CMV: Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/106 | Influenza virus infectious. NYMC BX-51B | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/114 | JC Virus (JCV) DNA (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/116 | Influenza virus infectious NYMC X-179A | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/118 | Influenza virus infectious B/Massachusetts/2/2012 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/140 | 1st International Standard for Anti EV71 Serum Human | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/144 | Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/146 | Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/148 | Human Blood Factor IX Concentrate (5th International Standard). | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/150 | Hepatitis C virus (HCV) For nucleic acid amplification techniques (5th International standard 2015) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/156 | Meningococcal group X polysaccharide (1st WHO International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/160 | High titre anti-A in IVIG working reference reagent | Working Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/174 | Botulinum Type A Antitoxin, Equine | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/198 | HBV,HCV,HIV Multiplex | European Certification | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/200 | Influenza Antigen A/Puerto Rico/8/34 (HINI) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/204 | Influenza Virus Infectious B/Brisbane/9/2014 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/206 | Influenza virus infectious NYMC X-247 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/210 | Biological activities of Rituximab WHO 1st International Standard | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/212 | BK Virus (BKV)(1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/224 | Influenza virus infectious. A/Switzerland/9715293/2013 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/226 | Influenza Virus Infectious A/South Australia/55/2014 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/228 | Influenza Virus Infectious A/Stockholm/6/2014 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/230 | Influenza Virus Infectious. A/Norway/466/2014 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/232 | Influenza Virus Infectious IVR-175 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/240 | British Working Standard for Anti-HCV | European Certification | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/242 | Anti-HCV (1 in 8 dilution)(British Working Standard) | European Certification | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/246 | Influenza Virus Infectious NIBRG-301 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/254 | Influenza Antigen A/Switzerland/9715293/2013 (NIB88) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/274 | Influenza Antigen B/Brisbane/9/2014 (Egg Derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/290 | 4th HCV RNA Genotype Panel for Nucleic Acid Amplification | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/300 | High titre anti-A and anti-B in serum (WHO Reference Reagent). | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/306 | Influenza Virus Infectious NYMC X-243 40180 E13 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/308 | Influenza Virus Infectious IVR-178 40200 E7 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/314 | Influenza Virus Infectious NIB-88 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/316 | Factor IX activated (FIXa) 2nd WHO International Standard | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/318 | Influenza Anti NIBRG-301 (H5) HA Serum (Sheep SH624 and SH625) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/320 | Influenza Virus Infectious B/Utah/9/2014 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/322 | Influenza Virus Infectious NIB-91 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/B651 | QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/B653 | QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/B654 | QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/B655 | QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/100 | Influenza Antigen B/Utah/9/2014 (Cell Derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/102 | Activated Blood Coagulation Factor X (FXa), Human | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/104 | Influenza Antigen A/South Australia/55/2014 Cell derived | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/106 | Ancrod | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/126 | Bordetella pertussis toxin (20µg). (2nd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/130 | Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT) | Clinical Virology Network | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/134 | Influenza Anti-A Switzerland/9715293/2013-Like HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/136 | EBOV RNA NP-VP35-GP in-run control | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/138 | EBOV RNA VP40-L in-run control | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/140 | Batroxobin | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/146 | Influenza Virus Infectious B/Brisbane/60/2008 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/148 | Influenza Virus Infectious NIB-92 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/150 | Influenza anti-B/Phuket/3073/2013 HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/154 | Influenza Virus Infectious NIB-93 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/158 | Influenza Virus Infectious NYMC X-263 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/160 | Influenza Virus Infectious NIBRG-306 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/174 | Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/180 | Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/182 | 7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate | Working Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/184 | Influenza Virus Infectious NYMC X-263B | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/188 | Influenza Virus Infectious NYMC X-263A | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/192 | Influenza Virus Infectious A/Hong Kong/4801/2014 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/194 | Influenza Virus Infectious NYMC X-257A | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/196 | Influenza Virus Infectious NYMC X-261 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/212 | Influenza Virus Infectious NYMC BX-53C | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/220 | Anti-EBOV plasma, human (WHO Reference Reagent) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/222 | EBOV RNA NP-VP35-GP (WHO Reference Reagent) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/224 | EBOV RNA VP40-L (WHO Reference Reagent) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/234 | Influenza Virus Infectious B/Texas/2/2013 41340 E7 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/238 | Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/240 | Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/242 | Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/248 | Influenza Anti A/Anhui/1/2013 (H7) HA Serum (Sheep SH644 & SH645) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/250 | Influenza Virus Infectious NYMC BX-31 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/252 | Influenza Virus Infectious A/California/7/2009 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/262 | 1st International Standard for Ebola virus (EBOV) antibodies Sierra Leone Convalescent Plasma Pool | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/266 | HHV-6 Virus 1st WHO International Standard | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/274 | Influenza Virus Infectious NYMC BX-59A | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/276 | Hepatitis A Virus (3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/294 | Influenza virus infectious NYMC BX-59B | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/296 | Sabin monovalent Polio vaccine type 2 (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/298 | Influenza Virus Infectious B/Brisbane/46/2015 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/300 | Influenza Virus Infectious NYMC BX-35 41950 E11 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/304 | Parathyroid hormone 1-34, recombinant, human, 2nd WHO International Standard | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/312 | Influenza Anti-B/Brisbane/60/2008 HA Serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B658 | QCRLYMEQC1 - Anti-Lyme QC1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B661 | QCRLYMEIgMQC1 - IgM Anti-Lyme QC1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B664 | QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B667 | QCRMEASQC1 Anti-MeaslesQC1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B669 | QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B671 | QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B673 | QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B678 | QCRPARVB19QC1 Anti-Parvovirus B19QC1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B680 | QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/104 | Norovirus GII Working reagent for Nucleic Acid Amplification Techniques | Clinical Virology Network | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/106 | Influenza antigen A/California/7/09 (H1N1) (NYMC-X181) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/108 | Influenza Virus Infectious A/PR/8/34 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/114 | Influenza anti - A/California/7/09 HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/118 | Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/120 | WHO 1st International Reference Panel for Genomic JAK2 V617F | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/124 | Zika Virus run Control (NAT) | Clinical Virology Network | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/126 | Native Vi polysaccharide (S. Typhi) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/138 | Anti-Typhoid capsular Vi polysaccharide Ig (Human) 1st WHO International Standar | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/154 | Blood Virology Multiplex II | Clinical Virology Network | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/158 | Influenza Antigen B/Phuket/3073/2013 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/164 | WHO OPV Reference bOPV 1+3 | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/170 | Infliximab(1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/182 | Influenza Anti-A/Hong Kong/4801/2014-like HA Serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/192 | Influenza Anti-B/Brisbane/60/2008 HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/194 | HIV-1 RNA (4th International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/196 | Sabin monovalent Polio vaccine type 1(1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/200 | Influenza Virus Infectious NIB-58 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/208 | Influenza Virus Infectious NIB-97 42090 E7 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/238 | Influenza Antigen A/Anhui/1/2013 (NIBRG-268) (H7N9) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/242 | Influenza Virus Infectious NIB-98 42110 E7 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/248 | Influenza Virus Infectious NYMC X-275 42020 E11 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/250 | 1st International Reference Panel for genomic KRAS codons 12 and 13 mutations | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/268 | Influenza Virus Infectious X-273 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/270 | Influenza Virus Infectious IVR-180 42400 E3/D7/E1 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/274 | Influenza Virus Infectious X-275A 42010 E13 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/282 | Influenza Virus Infectious X-285 42430 ExE1 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/284 | Antiserum to Respiratory Syncytial Virus WHO 1st International Standard | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/286 | Influenza Antigen A/Hong Kong/4801/2014 (NYMC X-263B) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/288 | Influenza Virus Infectious X-283A 42420 ExE1 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/290 | Influenza Virus Infectious X-285A 42440 ExE1 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/292 | Influenza Antigen A/Singapore/GP1908/2015 (IVR-180) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/344 | WHO Anti-EBOV Convalescent Plasma (International Reference Panel) | International Reference Preparation | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/360 | Influenza Virus Infectious NIB-96 41920 E7 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/362 | Influenza Virus Infectious NYMC X-291 42530 E8 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/366 | Influenza Virus Infectious NYMC X-291A 42540 E8 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/376 | Plasmodium falciparum antigens (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/B683 | QCRPARVB19IgMQC1 - IgM Anti-Parvovirus B19 Quality Control Reagent 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/B685 | QCRHIV2QC2-Anti HIV2: Quality Control Serum: Sample2 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/B687 | QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/B693 | QCRCMVIgMQC1 IgM Anti-CMV QC1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/B695 | QCRTOXOIgMQC1 IgM Anti-Toxoplasma gondii QC1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/B704 | QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/B706 | QCRHIV1p24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/106 | Influenza Anti-A/Michigan/45/2015-like HA Serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/126 | Influenza Virus Infectious NYMC BX-63A 42780 E10/E1 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/136 | Influenza Virus Infectious NIBRG-375 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/154 | Influenza Antigen A/Michigan/45/2015 (NYMC X-275) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/156 | Influenza Virus Infectious CNIC-1701 42910 E9 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/162 | Influenza Virus Infectious NYMC X-299 42920 E10 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/164 | Influenza Virus Infectious B/Maryland/15/2016 42800 E5 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/182 | Influenza Antigen A/Michigan/45/2015 (NYMC X-275) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/184 | Influenza Virus Infectious NIB-103 42610 E7 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/194 | Influenza Virus Infectious NIB-104 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/196 | Influenza Virus Infectious A/Singapore/INFIMH-16-0019/2016 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/206 | 14th British Standard for Coagulation Factor VIII Concentrate, Human. | Working Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/210 | Influenza Virus Infectious IVR-186 43310 E8 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/218 | Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (NIB-104) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/230 | Diphtheria Antitoxin Equine (DI) 10 IU/ml 1st International Standard | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/248 | Influenza Virus Infectious B/Phuket/3073/2013 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/252 | Influenza Virus Infectious NYMC BX-69 43220 E13 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/254 | Influenza Virus Infectious B/Colorado/6/2017 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/256 | Influenza Virus Infectious NYMC BX-69A | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/258 | Influenza Virus Infectious B/Alabama/2/2017 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/264 | Influenza Virus Infectious A/Michigan/45/2015 43470 E5 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/B710 | QCRTOXOQC1 - Anti-Toxoplasma gondii Quality Control Reagent Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/B713 | QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample 2 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/B717 | QCRHBsGQC1-HBsAg Quality Control Serum: Sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/B718 | QCRHBsGQC2-HBsAg Quality Control Serum: Sample2 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/B720 | QCRHIV1QC2-AntiHIV 1: Quality Control Serum: Sample 2 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/B723 | QCRHEVQC1 - Anti-Hepatitis E Quality Cotrol Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/B725 | QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 17/B728 | QCRHEVIgMQC1 - IgM Anti-Hepatitis E Quality Control Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 18/100 | Influenza Antigen B/Maryland/15/2016 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 18/104 | Influenza Antigen B/Maryland/15/2016 (NYMC BX-69A) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 18/108 | Influenza anti-A/Singapore/INFIMH-16-0019/2016- like HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 18/110 | Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (IVR-186) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 18/138 | Influenza Virus Infectious NYMC X-307A | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 18/140 | Influenza Virus Infectious NYMC X-307 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 18/160 | Influenza Virus Infectious NYMC X-311 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 18/166 | Influenza Virus Infectious NIB-112 43990 E6 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 18/168 | Influenza Virus Infectious A/Switzerland/8060/2017 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 18/170 | Influenza anti-B/Colorado/06/2017-like HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 234 | IPV ELISA MAbs Type 1, 2 and 3 (Type 1; No: 234) | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 2BADS | Anti-Brucella Abortus Serum, Bovine (International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 2CPBETAAT | Clostridium Perfringens Beta Antitoxin (2nd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 2CPEPAT | Clostridium Perfringens Epsilon Antitoxin (2nd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 520 | IPV ELISA MAbs Type 1, 2 and 3 (Type 3; No: 520) | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 59/015 | Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 59/016 | Corticotrophin (ACTH), Porcine (3rd International Standard) | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 59/021 | Botulinum Antitoxin Equine Type A | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 60/001 | Botulinum Antitoxin Equine Type B | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 60/013 | Tetanus Antitoxin, Equine, for Bioassay | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 61/001 | Botulinum Antitoxin Equine Type D (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 62/001 | Serum Gonadotrophin, Equine (2nd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 62/014 | Lysine Vasopressin, Porcine | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 63/005 | Gas Gangrene Antitoxin (Cl. Histolyticum), Equine | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 63/007 | Diphtheria Antitoxin, Equine, for Flocculation Test | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 64/002 | Rheumatoid Arthritis Serum | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 64/014 | Gas Gangrene Antitoxin (Cl. Septicum), Equine | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 64/024 | Gas Gangrene Antitoxin (Cl. Oedematiens), Equine | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 65/093 | Anti-Thyroglobulin Serum, Human (International Reference reagent) | International Reference Preparation | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 65/119 | Renin, Porcine | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 65/122 | Long-acting Thyroid Stimulator, Human | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 66/021 | Tetanus Antitoxin, Equine, for Flocculation Test | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 66/138 | Gastrin II, Porcine | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 66/153 | Diphtheria Antitoxin, Equine | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 66/233 | Anti-Nuclear Factor Serum (Homogenous) Human | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 67/037 | Immunoglobulin D (IgD) Serum, Human | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 67/086 | Immunoglobulins G, A, M Serum Human (International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 67/099 | Immunoglobulins G, A & M Serum Human | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 67/182 | Anti-Rubella Serum, Human | European Certification | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 67/183 | Primary Biliary Cirrhosis Serum, Human | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 68/340 | Anti-Nucleolar Factor Plasma, Human | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 68/356 | Renin, Human (International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 69/017 | Diphtheria Toxoid, Plain | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 69/065 | Autoimmune Antibody to Human Spermatazoa | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 69/194 | Glucagon, Porcine (First International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 70/302 | Angiotensin II (25µg) | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 71/281 | Anti-Malaria Plasma P Vivax | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 71/326 | Anti-Malaria Plasma Vivax Ng2 | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 72/092 | Anti-malaria Plasma: Plasmodium falciparum (Ghana) | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 72/096 | Anti-Malaria Serum (P.Malariae) | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 72/341 | Anti-Malaria Plasma P Falciparum | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 72/345 | Anti-Malaria Plasma P Falciparum | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 72/348 | Anti-Malaria Plasma P Vivax | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 73/517 | Anti-D (Rho) Antibodies, Human | European Certification | vial |
0.00
0.00 |
咨询 |
|